MP18 High Dose Antipsychotic Therapy (HDAT) guideline
All CWP staff
To identify those patients receiving high dose antipsychotic therapy and provide details of monitoring requirements to ensure patient safety.
Author and contact number
Policy dates & history
18 July 2017
18 July 2022
Medicines Management Group (MMG)